Carter Todd Alfred — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Carter Todd Alfred is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $41K.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-02-26VYGRVoyager Therapeutics, Inc.S — Open-market sale4.2K$3.76$16K
2026-02-20VYGRVoyager Therapeutics, Inc.S — Open-market sale3.3K$3.44$11K
2026-02-11VYGRVoyager Therapeutics, Inc.S — Open-market sale3.5K$3.85$14K
2026-02-10VYGRVoyager Therapeutics, Inc.A — Grant or award33.0K$0.00

Frequently Asked Questions

Who is Carter Todd Alfred?

Carter Todd Alfred is a corporate insider — currently tracked as Chief Scientific Officer. InsiderAlpha tracks every SEC Form 4 filing in real time.

Has Carter Todd Alfred been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($41K) across all tracked filings.

Where can I see all of Carter Todd Alfred's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Carter Todd Alfred profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.